2021
DOI: 10.1007/164_2021_456
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology of A-Type K+ Channels

Abstract: Transient outward potassium currents were first described nearly 60 years ago, since then major strides have been made in understanding their molecular basis and physiological roles. From the large family of voltage-gated potassium channels members of 3 subfamilies can produce such fast-inactivating A-type potassium currents. Each subfamily gives rise to currents with distinct biophysical properties and pharmacological profiles and a simple workflow is provided to aid the identification of channels mediating A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 87 publications
0
2
0
Order By: Relevance
“…3c and Table 2). That is, the Va 1/2 of A-type voltage-gated K + currents in type III cells was 17.9 ± 4.5 mV (n = 17), which bears resemblance to the Va 1/2 of Kv3.3 and Kv3.4 channels at ~ 7 and 13-19 mV, respectively, which are more depolarized values as compared to the other A-type K + channels (Coetzee et al 1999;Fernandez et al 2003;Johnston 2021). Therefore, it suggests that type III cells express high voltage-activated A-type K + channels.…”
Section: Voltage Dependency Of Activation and Steady-state Inactivationmentioning
confidence: 74%
“…3c and Table 2). That is, the Va 1/2 of A-type voltage-gated K + currents in type III cells was 17.9 ± 4.5 mV (n = 17), which bears resemblance to the Va 1/2 of Kv3.3 and Kv3.4 channels at ~ 7 and 13-19 mV, respectively, which are more depolarized values as compared to the other A-type K + channels (Coetzee et al 1999;Fernandez et al 2003;Johnston 2021). Therefore, it suggests that type III cells express high voltage-activated A-type K + channels.…”
Section: Voltage Dependency Of Activation and Steady-state Inactivationmentioning
confidence: 74%
“…The molecular basis of this functional diversity resides in 40 Kv channel genes classi ed in 12 sub-families and many additional genes encoding ancillary beta subunits, which are differentially expressed in relevant tissues and parts of the brain and different subcellular compartments [3][4][5][6] . This diversity has stimulated a special interest in developing small-molecules and peptides that could selectively modulate aspects of function in excitable tissues and, therefore, could have potential as novel medicinal agents [7][8][9][10][11][12] . The search for Kv channel openers or positive allosteric modulators (PAMs) has gained most of the attention because they could help treat common hyperexcitability disorders (epilepsy, neuropathic pain, tinnitus, cardiac arrhythmias, etc.)…”
Section: Introductionmentioning
confidence: 99%